These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9928061)

  • 1. Neuromodulator role of VIP in recovery of rat behavior and brain neurotransmitters level after frontal lobectomy.
    Karganov M; Romanova G; Braslawsky W; Tarshitz D; Telegdy G
    Ann N Y Acad Sci; 1998 Dec; 865():519-22. PubMed ID: 9928061
    [No Abstract]   [Full Text] [Related]  

  • 2. [Change in the level of vasoactive intestinal peptide in the cerebral cortex and hypothalamus and behavioral reactions of rats after frontal lobectomy].
    Karganov MIu; Romanova GA; Goriacheva TV; Kadar T; Telegdi D
    Patol Fiziol Eksp Ter; 1991; (2):9-11. PubMed ID: 1881717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of vasoactive intestinal peptide on dopaminergic system in the rat brain.
    Itoh S; Katsuura G; Takashima A
    Peptides; 1988; 9(2):315-7. PubMed ID: 3375138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The regulatory effect of VIP on exploratory behavior of the rat and on the neuromediator level in the normal brain and in frontal lobectomy].
    Romanova GA; Karganov MIu
    Fiziol Zh SSSR Im I M Sechenova; 1989 May; 75(5):670-6. PubMed ID: 2569988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraventricular injection of neostigmine increases dopaminergic and noradrenergic nerve activities: hyperglycemic effects and neurotransmitters in the hypothalamus.
    Takahashi A; Ishimaru H; Ikarashi Y; Maruyama Y
    Neurosci Lett; 1993 Jun; 156(1-2):54-6. PubMed ID: 7692365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase of prolactin mRNA in the rat hypothalamus after intracerebroventricular injection of VIP or PACAP.
    Bredow S; Kacsóh B; Obál F; Fang J; Krueger JM
    Brain Res; 1994 Oct; 660(2):301-8. PubMed ID: 7820699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Permissive effect of VIP on the hyperglycemic response induced by 2-deoxy-D-glucose.
    Shimizu K; Hibino H; Komenami N; Nagai N; Nagai K; Nakagawa H
    Neurosci Lett; 1994 Jul; 175(1-2):157-60. PubMed ID: 7970200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of low doses of intracerebroventricular 6-OHDA on the levels of monoaminergic neurotransmitters in rat brain structures.
    Sadakierska-Chudy A; Haduch A; Gołembiowska K; Daniel WA
    Pharmacol Rep; 2010; 62(6):1225-30. PubMed ID: 21273682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of vasoactive intestinal polypeptide on choroid plexus blood flow and cerebrospinal fluid production.
    Nilsson C; Lindvall-Axelsson M; Owman C
    Prog Brain Res; 1992; 91():445-9. PubMed ID: 1329148
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of dibutyryl cyclic GMP on the content of biogenic amines in discrete areas of brain and on the behaviour of rats.
    Herman ZS; Kmieciak-Kołada K
    Med Biol; 1978 Jun; 56(3):128-32. PubMed ID: 210334
    [No Abstract]   [Full Text] [Related]  

  • 11. Evidence that noradrenergic activity does not mediate the inhibition of luteinizing hormone secretion caused by vasoactive intestinal peptide.
    Alexander MJ; Clifton DK; Matsumoto AM; Steiner RA
    Brain Res; 1988 Apr; 445(2):247-53. PubMed ID: 3130956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropeptides in the cerebrospinal fluid and regulation of behavior.
    Schwarzberg H; Pross M
    Prog Brain Res; 1992; 91():455-7. PubMed ID: 1357723
    [No Abstract]   [Full Text] [Related]  

  • 13. Changes in brain monoaminergic neurotransmitter concentrations in rat after intracerebroventricular injection of streptozotocin.
    Ding A; Nitsch R; Hoyer S
    J Cereb Blood Flow Metab; 1992 Jan; 12(1):103-9. PubMed ID: 1370067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of di-butyltin dilaurate on brain neurotransmitter systems and behavior in rats.
    Alam MS; Husain R; Srivastava SP; Seth PK
    Arch Toxicol; 1988 Apr; 61(5):373-7. PubMed ID: 2899427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decrease of rapid-eye-movement sleep in the light by intraventricular application of a VIP-antagonist in the rat.
    Mirmiran M; Kruisbrink J; Bos NP; Van der Werf D; Boer GJ
    Brain Res; 1988 Aug; 458(1):192-4. PubMed ID: 3208098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of vasopressin and oxytocin on behavioral processes and brain neurotransmitter metabolism in rats.
    Telegdy G; Kovacs GL
    Neurosci Behav Physiol; 1981; 11(5):429-33. PubMed ID: 6125912
    [No Abstract]   [Full Text] [Related]  

  • 17. Neonatal sympathectomy by 6-hydroxydopamine in the rat: no effects on behavior by changes in endogenous brain norepinephrine.
    Pappas BA; Sobrian SK
    Life Sci I; 1972 Jul; 11(14):653-9. PubMed ID: 4656097
    [No Abstract]   [Full Text] [Related]  

  • 18. [Neurochemical characteristics of specific pathological syndrome originating under conditions of stress states].
    Anokhina IP
    Vestn Akad Med Nauk SSSR; 1975; (8):34-43. PubMed ID: 240242
    [No Abstract]   [Full Text] [Related]  

  • 19. Regional distribution to recovery of 5-HT levels after administration of "atrophins" MDMA and D,L-fenfluramine. Stereospecificity and comparison with 5,7-dihydroxytryptamine.
    Lehmann J; DeSouza EB; Culp S; Zaczek R
    Ann N Y Acad Sci; 1992 May; 648():291-5. PubMed ID: 1379013
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of neurotransmitters in the neocortex.
    Coyle JT
    Neurosci Res Program Bull; 1982 Apr; 20(4):479-91. PubMed ID: 6126844
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.